Shuo Sun

机构：Chinese Academy of Sciences · ORCID：0000-0003-2022-0425

发表论文 17 篇 · 总被引 152 次 · h-index 5

代表论文

• Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma (2020 · International Journal of Nanomedicine · 被引 57)
• Immunostimulant In Situ Hydrogel Improves Synergetic Radioimmunotherapy of Malignant Glioblastoma Relapse Post‐Resection (2022 · Advanced Functional Materials · 被引 53)
• Targeting GOLPH3L improves glioblastoma radiotherapy by regulating STING-NLRP3–mediated tumor immune microenvironment reprogramming (2025 · Science Translational Medicine · 被引 20)
• Intelligent Nanoparticles With pH-Sensitive Co-Delivery of Temozolomide and siEGFR to Ameliorate Glioma Therapy (2022 · Frontiers in Genetics · 被引 11)
• Anticancer Activity of Released Doxorubicin from a Folate-Mediated Polyelectrolyte Complex (2011 · Journal of Biomaterials Science Polymer Edition · 被引 7)
• LINC01088 Targets miR-195-5p to Promote Proliferation and Migration and Reduce Apoptosis in the Inhibition of Carotid Artery Stenosis (2025 · Clinical and Applied Thrombosis/Hemostasis · 被引 3)